Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Invasive Breast Carcinoma|Stage II Breast Cancer AJCC v6 and v7|Stage III Breast Cancer AJCC v7|Triple-Negative Breast Carcinoma
Interventions: DRUG: Atezolizumab|PROCEDURE: Biospecimen Collection|DRUG: Carboplatin|PROCEDURE: Lumpectomy|PROCEDURE: Mastectomy|DRUG: Paclitaxel
Sponsor: National Cancer Institute (NCI)